-
1
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 363(8):711-23. doi:10.1056/NEJMoa1003466
-
(2010)
N Engl J Med
, vol.363
, Issue.8
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
-
2
-
-
84936791837
-
Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer
-
Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med (2015) 373(2):123-35. doi:10.1056/NEJMoa1504627
-
(2015)
N Engl J Med
, vol.373
, Issue.2
, pp. 123-135
-
-
Brahmer, J.1
Reckamp, K.L.2
Baas, P.3
Crino, L.4
Eberhardt, W.E.5
Poddubskaya, E.6
-
3
-
-
84908354848
-
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
-
Robert C, Ribas A, Wolchok JD, Hodi FS, Hamid O, Kefford R, et al. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet (2014) 384(9948):1109-17. doi:10.1016/S0140-6736(14)60958-2
-
(2014)
Lancet
, vol.384
, Issue.9948
, pp. 1109-1117
-
-
Robert, C.1
Ribas, A.2
Wolchok, J.D.3
Hodi, F.S.4
Hamid, O.5
Kefford, R.6
-
4
-
-
84862769116
-
An immune-active tumor microenvironment favors clinical response to ipilimumab
-
Ji RR, Chasalow SD, Wang L, Hamid O, Schmidt H, Cogswell J, et al. An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol Immunother (2012) 61(7):1019-31. doi:10.1007/s00262-011-1172-6
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.7
, pp. 1019-1031
-
-
Ji, R.R.1
Chasalow, S.D.2
Wang, L.3
Hamid, O.4
Schmidt, H.5
Cogswell, J.6
-
5
-
-
0034041033
-
Immunobiology of dendritic cells
-
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol (2000) 18:767-811. doi:10.1146/annurev.immunol.18.1.767
-
(2000)
Annu Rev Immunol
, vol.18
, pp. 767-811
-
-
Banchereau, J.1
Briere, F.2
Caux, C.3
Davoust, J.4
Lebecque, S.5
Liu, Y.J.6
-
6
-
-
84901405092
-
Clinical use of dendritic cells for cancer therapy
-
Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Clinical use of dendritic cells for cancer therapy. Lancet Oncol (2014) 15(7):e257-67. doi:10.1016/S1470-2045(13)70585-0
-
(2014)
Lancet Oncol
, vol.15
, Issue.7
, pp. e257-e267
-
-
Anguille, S.1
Smits, E.L.2
Lion, E.3
van Tendeloo, V.F.4
Berneman, Z.N.5
-
7
-
-
84933048332
-
Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis
-
Cao JX, Zhang XY, Liu JL, Li D, Li JL, Liu YS, et al. Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis. PLoS One (2014) 9(9):e107173. doi:10.1371/journal.pone.0107173
-
(2014)
PLoS One
, vol.9
, Issue.9
-
-
Cao, J.X.1
Zhang, X.Y.2
Liu, J.L.3
Li, D.4
Li, J.L.5
Liu, Y.S.6
-
8
-
-
77956300537
-
Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
-
Nakai N, Hartmann G, Kishimoto S, Katoh N. Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters. Pigment Cell Melanoma Res (2010) 23(5):607-19. doi:10.1111/j.1755-148X.2010.00736.x
-
(2010)
Pigment Cell Melanoma Res
, vol.23
, Issue.5
, pp. 607-619
-
-
Nakai, N.1
Hartmann, G.2
Kishimoto, S.3
Katoh, N.4
-
9
-
-
77955066199
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
-
KantoffPW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med (2010) 363(5):411-22. doi:10.1056/NEJMoa1001294
-
(2010)
N Engl J Med
, vol.363
, Issue.5
, pp. 411-422
-
-
Kantoff, P.W.1
Higano, C.S.2
Shore, N.D.3
Berger, E.R.4
Small, E.J.5
Penson, D.F.6
-
10
-
-
84866060623
-
Immunotherapy of cancer in 2012
-
Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin (2012) 62(5):309-35. doi:10.3322/caac.20132
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.5
, pp. 309-335
-
-
Kirkwood, J.M.1
Butterfield, L.H.2
Tarhini, A.A.3
Zarour, H.4
Kalinski, P.5
Ferrone, S.6
-
11
-
-
84860188105
-
Therapeutic cancer vaccines: current status and moving forward
-
Schlom J. Therapeutic cancer vaccines: current status and moving forward. J Natl Cancer Inst (2012) 104(8):599-613. doi:10.1093/jnci/djs033
-
(2012)
J Natl Cancer Inst
, vol.104
, Issue.8
, pp. 599-613
-
-
Schlom, J.1
-
12
-
-
53449090440
-
Overcoming immunosuppressive mechanisms
-
Widen K, Mozaffari F, Choudhury A, Mellstedt H. Overcoming immunosuppressive mechanisms. Ann Oncol (2008) 19(Suppl 7):vii241-7. doi:10.1093/annonc/mdn459
-
(2008)
Ann Oncol
, vol.19
, pp. vii241-vii247
-
-
Widen, K.1
Mozaffari, F.2
Choudhury, A.3
Mellstedt, H.4
-
13
-
-
77953468036
-
Directing dendritic cell immunotherapy towards successful cancer treatment
-
Sabado RL, Bhardwaj N. Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy (2010) 2(1):37-56. doi:10.2217/imt.09.43
-
(2010)
Immunotherapy
, vol.2
, Issue.1
, pp. 37-56
-
-
Sabado, R.L.1
Bhardwaj, N.2
-
14
-
-
84883466843
-
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
-
Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, et al. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res (2013) 19(17):4801-15. doi:10.1158/1078-0432.CCR-13-1185
-
(2013)
Clin Cancer Res
, vol.19
, Issue.17
, pp. 4801-4815
-
-
Chiang, C.L.1
Kandalaft, L.E.2
Tanyi, J.3
Hagemann, A.R.4
Motz, G.T.5
Svoronos, N.6
-
15
-
-
0344585451
-
Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma
-
Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol (2003) 171(11):5940-7. doi:10.4049/jimmunol.171.11.5940
-
(2003)
J Immunol
, vol.171
, Issue.11
, pp. 5940-5947
-
-
Goldszmid, R.S.1
Idoyaga, J.2
Bravo, A.I.3
Steinman, R.4
Mordoh, J.5
Wainstok, R.6
-
16
-
-
55149118703
-
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
-
Hatfield P, Merrick AE, West E, O'Donnell D, Selby P, Vile R, et al. Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother (2008) 31(7):620-32. doi:10.1097/CJI.0b013e31818213df
-
(2008)
J Immunother
, vol.31
, Issue.7
, pp. 620-632
-
-
Hatfield, P.1
Merrick, A.E.2
West, E.3
O'Donnell, D.4
Selby, P.5
Vile, R.6
-
17
-
-
31544449978
-
Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
-
Kim HS, Choo YS, Koo T, Bang S, Oh TY, Wen J, et al. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer. Immunol Lett (2006) 103(2):142-8. doi:10.1016/j.imlet.2005.10.021
-
(2006)
Immunol Lett
, vol.103
, Issue.2
, pp. 142-148
-
-
Kim, H.S.1
Choo, Y.S.2
Koo, T.3
Bang, S.4
Oh, T.Y.5
Wen, J.6
-
18
-
-
84959386808
-
-
Oncoimmunology
-
Vandenberk L, Garg AD, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology (2015). doi:10.1080/2162402X.2015.1083669
-
(2015)
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
-
-
Vandenberk, L.1
Garg, A.D.2
Verschuere, T.3
Koks, C.4
Belmans, J.5
Beullens, M.6
-
19
-
-
0035890823
-
Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization
-
Kotera Y, Shimizu K, Mule JJ. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res (2001) 61(22):8105-9.
-
(2001)
Cancer Res
, vol.61
, Issue.22
, pp. 8105-8109
-
-
Kotera, Y.1
Shimizu, K.2
Mule, J.J.3
-
20
-
-
84890034987
-
Danger signalling during cancer cell death: origins, plasticity and regulation
-
Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ (2014) 21(1):26-38. doi:10.1038/cdd.2013.48
-
(2014)
Cell Death Differ
, vol.21
, Issue.1
, pp. 26-38
-
-
Garg, A.D.1
Martin, S.2
Golab, J.3
Agostinis, P.4
-
21
-
-
84923247523
-
Consensus guidelines for the detection of immunogenic cell death
-
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology (2014) 3(9):e955691. doi:10.4161/21624011.2014.955691
-
(2014)
Oncoimmunology
, vol.3
, Issue.9
-
-
Kepp, O.1
Senovilla, L.2
Vitale, I.3
Vacchelli, E.4
Adjemian, S.5
Agostinis, P.6
-
23
-
-
34548576109
-
Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis
-
Obeid M, Panaretakis T, Joza N, TufiR, Tesniere A, van Endert P, et al. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ (2007) 14(10):1848-50. doi:10.1038/sj.cdd.4402201
-
(2007)
Cell Death Differ
, vol.14
, Issue.10
, pp. 1848-1850
-
-
Obeid, M.1
Panaretakis, T.2
Joza, N.3
Tufi, R.4
Tesniere, A.5
van Endert, P.6
-
24
-
-
55749106392
-
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity
-
Brusa D, Garetto S, Chiorino G, Scatolini M, Migliore E, Camussi G, et al. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity. Vaccine (2008) 26(50):6422-32. doi:10.1016/j.vaccine.2008.08.063
-
(2008)
Vaccine
, vol.26
, Issue.50
, pp. 6422-6432
-
-
Brusa, D.1
Garetto, S.2
Chiorino, G.3
Scatolini, M.4
Migliore, E.5
Camussi, G.6
-
25
-
-
84944457204
-
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
-
Creaney J, Ma S, Sneddon SA, Tourigny MR, Dick IM, Leon JS, et al. Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen. Oncoimmunology (2015) 4(7):e1011492. doi:10.1080/2162402X.2015.1011492
-
(2015)
Oncoimmunology
, vol.4
, Issue.7
-
-
Creaney, J.1
Ma, S.2
Sneddon, S.A.3
Tourigny, M.R.4
Dick, I.M.5
Leon, J.S.6
-
26
-
-
0347363718
-
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection
-
Di Nicola M, Napoli S, Anichini A, Mortarini R, Romagnoli L, Magni M, et al. Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection. Haematologica (2003) 88(12):1396-404.
-
(2003)
Haematologica
, vol.88
, Issue.12
, pp. 1396-1404
-
-
Di Nicola, M.1
Napoli, S.2
Anichini, A.3
Mortarini, R.4
Romagnoli, L.5
Magni, M.6
-
27
-
-
0034235599
-
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
-
Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res (2000) 60(13):3542-9.
-
(2000)
Cancer Res
, vol.60
, Issue.13
, pp. 3542-3549
-
-
Hoffmann, T.K.1
Meidenbauer, N.2
Dworacki, G.3
Kanaya, H.4
Whiteside, T.L.5
-
28
-
-
79251580687
-
Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity
-
Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, Hartvigsen K, et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res (2011) 108(2):235-48. doi:10.1161/CIRCRESAHA.110.223875
-
(2011)
Circ Res
, vol.108
, Issue.2
, pp. 235-248
-
-
Miller, Y.I.1
Choi, S.H.2
Wiesner, P.3
Fang, L.4
Harkewicz, R.5
Hartvigsen, K.6
-
29
-
-
80051935634
-
Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress
-
Moghaddam AE, Gartlan KH, Kong L, Sattentau QJ. Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress. J Immunol (2011) 187(4):1626-33. doi:10.4049/jimmunol.1003906
-
(2011)
J Immunol
, vol.187
, Issue.4
, pp. 1626-1633
-
-
Moghaddam, A.E.1
Gartlan, K.H.2
Kong, L.3
Sattentau, Q.J.4
-
30
-
-
33746894710
-
Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells
-
Chiang CL, Ledermann JA, Rad AN, Katz DR, Chain BM. Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. Cancer Immunol Immunother (2006) 55(11):1384-95. doi:10.1007/s00262-006-0127-9
-
(2006)
Cancer Immunol Immunother
, vol.55
, Issue.11
, pp. 1384-1395
-
-
Chiang, C.L.1
Ledermann, J.A.2
Rad, A.N.3
Katz, D.R.4
Chain, B.M.5
-
31
-
-
0031762701
-
Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells
-
Carrasco-Marin E, Paz-Miguel JE, Lopez-Mato P, Alvarez-Dominguez C, Leyva-Cobian F. Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology (1998) 95(3):314-21. doi:10.1046/j.1365-2567.1998.00618.x
-
(1998)
Immunology
, vol.95
, Issue.3
, pp. 314-321
-
-
Carrasco-Marin, E.1
Paz-Miguel, J.E.2
Lopez-Mato, P.3
Alvarez-Dominguez, C.4
Leyva-Cobian, F.5
-
32
-
-
0036892577
-
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells
-
Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood (2002) 100(12):4108-15. doi:10.1182/blood-2002-05-1389
-
(2002)
Blood
, vol.100
, Issue.12
, pp. 4108-4115
-
-
Feng, H.1
Zeng, Y.2
Graner, M.W.3
Katsanis, E.4
-
33
-
-
67650891871
-
Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
-
Brusa D, Migliore E, Garetto S, Simone M, Matera L. Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells. Prostate (2009) 69(12):1343-52. doi:10.1002/pros.20981
-
(2009)
Prostate
, vol.69
, Issue.12
, pp. 1343-1352
-
-
Brusa, D.1
Migliore, E.2
Garetto, S.3
Simone, M.4
Matera, L.5
-
34
-
-
32044456037
-
Hyperthermia enhances CTL cross-priming
-
Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, et al. Hyperthermia enhances CTL cross-priming. J Immunol (2006) 176(4):2134-41. doi:10.4049/jimmunol.176.4.2134
-
(2006)
J Immunol
, vol.176
, Issue.4
, pp. 2134-2141
-
-
Shi, H.1
Cao, T.2
Connolly, J.E.3
Monnet, L.4
Bennett, L.5
Chapel, S.6
-
35
-
-
84865138542
-
Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma
-
Suzuki Y, Mimura K, Yoshimoto Y, Watanabe M, Ohkubo Y, Izawa S, et al. Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Cancer Res (2012) 72(16):3967-76. doi:10.1158/0008-5472.CAN-12-0851
-
(2012)
Cancer Res
, vol.72
, Issue.16
, pp. 3967-3976
-
-
Suzuki, Y.1
Mimura, K.2
Yoshimoto, Y.3
Watanabe, M.4
Ohkubo, Y.5
Izawa, S.6
-
36
-
-
79960369894
-
Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment
-
Stangl S, Themelis G, Friedrich L, Ntziachristos V, Sarantopoulos A, Molls M, et al. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment. Radiother Oncol (2011) 99(3):313-6. doi:10.1016/j.radonc.2011.05.051
-
(2011)
Radiother Oncol
, vol.99
, Issue.3
, pp. 313-316
-
-
Stangl, S.1
Themelis, G.2
Friedrich, L.3
Ntziachristos, V.4
Sarantopoulos, A.5
Molls, M.6
-
37
-
-
10844269645
-
Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells
-
Prasad SJ, Farrand KJ, Matthews SA, Chang JH, McHugh RS, Ronchese F. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells. J Immunol (2005) 174(1):90-8. doi:10.4049/jimmunol.174.1.90
-
(2005)
J Immunol
, vol.174
, Issue.1
, pp. 90-98
-
-
Prasad, S.J.1
Farrand, K.J.2
Matthews, S.A.3
Chang, J.H.4
McHugh, R.S.5
Ronchese, F.6
-
38
-
-
84863619632
-
Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation
-
Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, et al. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J Immunol (2012) 189(2):558-66. doi:10.4049/jimmunol.1200563
-
(2012)
J Immunol
, vol.189
, Issue.2
, pp. 558-566
-
-
Gupta, A.1
Probst, H.C.2
Vuong, V.3
Landshammer, A.4
Muth, S.5
Yagita, H.6
-
39
-
-
34249326159
-
Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression
-
Huang J, Wang Y, Guo J, Lu H, Lin X, Ma L, et al. Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression. Clin Immunol (2007) 123(3):298-310. doi:10.1016/j.clim.2007.02.005
-
(2007)
Clin Immunol
, vol.123
, Issue.3
, pp. 298-310
-
-
Huang, J.1
Wang, Y.2
Guo, J.3
Lu, H.4
Lin, X.5
Ma, L.6
-
40
-
-
0037086079
-
Strategies for antigen loading of dendritic cells to enhance the antitumor immune response
-
Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res (2002) 62(6):1884-9.
-
(2002)
Cancer Res
, vol.62
, Issue.6
, pp. 1884-1889
-
-
Strome, S.E.1
Voss, S.2
Wilcox, R.3
Wakefield, T.L.4
Tamada, K.5
Flies, D.6
-
41
-
-
84871015953
-
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
-
Chen HM, Wang PH, Chen SS, Wen CC, Chen YH, Yang WC, et al. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunol Immunother (2012) 61(11):1989-2002. doi:10.1007/s00262-012-1258-9
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 1989-2002
-
-
Chen, H.M.1
Wang, P.H.2
Chen, S.S.3
Wen, C.C.4
Chen, Y.H.5
Yang, W.C.6
-
42
-
-
84902543448
-
High hydrostatic pressure induces immunogenic cell death in human tumor cells
-
Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, et al. High hydrostatic pressure induces immunogenic cell death in human tumor cells. Int J Cancer (2014) 135(5):1165-77. doi:10.1002/ijc.28766
-
(2014)
Int J Cancer
, vol.135
, Issue.5
, pp. 1165-1177
-
-
Fucikova, J.1
Moserova, I.2
Truxova, I.3
Hermanova, I.4
Vancurova, I.5
Partlova, S.6
-
43
-
-
84860520650
-
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus
-
Diaconu I, Cerullo V, Hirvinen ML, Escutenaire S, Ugolini M, Pesonen SK, et al. Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus. Cancer Res (2012) 72(9):2327-38. doi:10.1158/0008-5472.CAN-11-2975
-
(2012)
Cancer Res
, vol.72
, Issue.9
, pp. 2327-2338
-
-
Diaconu, I.1
Cerullo, V.2
Hirvinen, M.L.3
Escutenaire, S.4
Ugolini, M.5
Pesonen, S.K.6
-
44
-
-
84861112821
-
Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma
-
Miyamoto S, Inoue H, Nakamura T, Yamada M, Sakamoto C, Urata Y, et al. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma. Cancer Res (2012) 72(10):2609-21. doi:10.1158/0008-5472.CAN-11-3185
-
(2012)
Cancer Res
, vol.72
, Issue.10
, pp. 2609-2621
-
-
Miyamoto, S.1
Inoue, H.2
Nakamura, T.3
Yamada, M.4
Sakamoto, C.5
Urata, Y.6
-
45
-
-
84918574716
-
Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
-
Koks CA, Garg AD, Ehrhardt M, Riva M, Vandenberk L, Boon L, et al. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death. Int J Cancer (2015) 136(5):E313-25. doi:10.1002/ijc.29202
-
(2015)
Int J Cancer
, vol.136
, Issue.5
, pp. E313-E325
-
-
Koks, C.A.1
Garg, A.D.2
Ehrhardt, M.3
Riva, M.4
Vandenberk, L.5
Boon, L.6
-
46
-
-
84871985834
-
Measles virus causes immunogenic cell death in human melanoma
-
Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, et al. Measles virus causes immunogenic cell death in human melanoma. Gene Ther (2013) 20(1):7-15. doi:10.1038/gt.2011.205
-
(2013)
Gene Ther
, vol.20
, Issue.1
, pp. 7-15
-
-
Donnelly, O.G.1
Errington-Mais, F.2
Steele, L.3
Hadac, E.4
Jennings, V.5
Scott, K.6
-
47
-
-
0036780171
-
Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients
-
Bai L, Koopmann J, Fiola C, Fournier P, Schirrmacher V. Dendritic cells pulsed with viral oncolysates potently stimulate autologous T cells from cancer patients. Int J Oncol (2002) 21(4):685-94. doi:10.3892/ijo.21.4.685
-
(2002)
Int J Oncol
, vol.21
, Issue.4
, pp. 685-694
-
-
Bai, L.1
Koopmann, J.2
Fiola, C.3
Fournier, P.4
Schirrmacher, V.5
-
48
-
-
84856696459
-
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
-
Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother (2012) 61(2):215-21. doi:10.1007/s00262-011-1184-2
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.2
, pp. 215-221
-
-
Garg, A.D.1
Krysko, D.V.2
Vandenabeele, P.3
Agostinis, P.4
-
49
-
-
84857997683
-
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
-
Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J (2012) 31(5):1062-79. doi:10.1038/emboj.2011.497
-
(2012)
EMBO J
, vol.31
, Issue.5
, pp. 1062-1079
-
-
Garg, A.D.1
Krysko, D.V.2
Verfaillie, T.3
Kaczmarek, A.4
Ferreira, G.B.5
Marysael, T.6
-
50
-
-
84887445500
-
Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene. LAMP2A
-
Garg AD, Dudek AM, Agostinis P. Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene. LAMP2A. Cell Death Dis (2013) 4:e826. doi:10.1038/cddis.2013.372
-
(2013)
Cell Death Dis
, vol.4
-
-
Garg, A.D.1
Dudek, A.M.2
Agostinis, P.3
-
51
-
-
13444271569
-
Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response
-
Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res (2005) 65(3):1018-26.
-
(2005)
Cancer Res
, vol.65
, Issue.3
, pp. 1018-1026
-
-
Korbelik, M.1
Sun, J.2
Cecic, I.3
-
52
-
-
80054112699
-
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
-
Korbelik M, Zhang W, Merchant S. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunol Immunother (2011) 60(10):1431-7. doi:10.1007/s00262-011-1047-x
-
(2011)
Cancer Immunol Immunother
, vol.60
, Issue.10
, pp. 1431-1437
-
-
Korbelik, M.1
Zhang, W.2
Merchant, S.3
-
53
-
-
84879783969
-
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
-
Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy (2013) 9(9):1292-307. doi:10.4161/auto.25399
-
(2013)
Autophagy
, vol.9
, Issue.9
, pp. 1292-1307
-
-
Garg, A.D.1
Dudek, A.M.2
Ferreira, G.B.3
Verfaillie, T.4
Vandenabeele, P.5
Krysko, D.V.6
-
54
-
-
84890285799
-
Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
-
Garg AD, Dudek AM, Agostinis P. Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity. Oncoimmunology (2013) 2(10):e26260. doi:10.4161/onci.26260
-
(2013)
Oncoimmunology
, vol.2
, Issue.10
-
-
Garg, A.D.1
Dudek, A.M.2
Agostinis, P.3
-
55
-
-
0037086260
-
Generation of effective antitumor vaccines using photodynamic therapy
-
Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res (2002) 62(6):1604-8.
-
(2002)
Cancer Res
, vol.62
, Issue.6
, pp. 1604-1608
-
-
Gollnick, S.O.1
Vaughan, L.2
Henderson, B.W.3
-
56
-
-
33646376719
-
Photodynamic therapy-generated vaccine for cancer therapy
-
Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother (2006) 55(8):900-9. doi:10.1007/s00262-005-0088-4
-
(2006)
Cancer Immunol Immunother
, vol.55
, Issue.8
, pp. 900-909
-
-
Korbelik, M.1
Sun, J.2
-
57
-
-
78549275158
-
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
-
Zappasodi R, Pupa SM, Ghedini GC, Bongarzone I, Magni M, Cabras AD, et al. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death. Cancer Res (2010) 70(22):9062-72. doi:10.1158/0008-5472.CAN-10-1825
-
(2010)
Cancer Res
, vol.70
, Issue.22
, pp. 9062-9072
-
-
Zappasodi, R.1
Pupa, S.M.2
Ghedini, G.C.3
Bongarzone, I.4
Magni, M.5
Cabras, A.D.6
-
58
-
-
49649113879
-
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
-
De Vleeschouwer S, Fieuws S, Rutkowski S, Van Calenbergh F, Van Loon J, Goffin J, et al. Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. Clin Cancer Res (2008) 14(10):3098-104. doi:10.1158/1078-0432.CCR-07-4875
-
(2008)
Clin Cancer Res
, vol.14
, Issue.10
, pp. 3098-3104
-
-
De Vleeschouwer, S.1
Fieuws, S.2
Rutkowski, S.3
Van Calenbergh, F.4
Van Loon, J.5
Goffin, J.6
-
59
-
-
77649123099
-
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
-
Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, et al. Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatr Blood Cancer (2010) 54(4):519-25. doi:10.1002/pbc.22319
-
(2010)
Pediatr Blood Cancer
, vol.54
, Issue.4
, pp. 519-525
-
-
Ardon, H.1
De Vleeschouwer, S.2
Van Calenbergh, F.3
Claes, L.4
Kramm, C.M.5
Rutkowski, S.6
-
60
-
-
77956061272
-
Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study
-
Ardon H, Van Gool S, Lopes IS, Maes W, Sciot R, Wilms G, et al. Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study. J Neurooncol (2010) 99(2):261-72. doi:10.1007/s11060-010-0131-y
-
(2010)
J Neurooncol
, vol.99
, Issue.2
, pp. 261-272
-
-
Ardon, H.1
Van Gool, S.2
Lopes, I.S.3
Maes, W.4
Sciot, R.5
Wilms, G.6
-
61
-
-
84870985481
-
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
-
Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, et al. Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial. Cancer Immunol Immunother (2012) 61(11):2033-44. doi:10.1007/s00262-012-1261-1
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 2033-2044
-
-
Ardon, H.1
Van Gool, S.W.2
Verschuere, T.3
Maes, W.4
Fieuws, S.5
Sciot, R.6
-
62
-
-
84870982871
-
Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
-
De Vleeschouwer S, Ardon H, Van Calenbergh F, Sciot R, Wilms G, van Loon J, et al. Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination. Cancer Immunol Immunother (2012) 61(11):2105-12. doi:10.1007/s00262-012-1271-z
-
(2012)
Cancer Immunol Immunother
, vol.61
, Issue.11
, pp. 2105-2112
-
-
De Vleeschouwer, S.1
Ardon, H.2
Van Calenbergh, F.3
Sciot, R.4
Wilms, G.5
van Loon, J.6
-
64
-
-
79955591522
-
Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy
-
Fadul CE, Fisher JL, Hampton TH, Lallana EC, Li Z, Gui J, et al. Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy. J Immunother (2011) 34(4):382-9. doi:10.1097/CJI.0b013e318215e300
-
(2011)
J Immunother
, vol.34
, Issue.4
, pp. 382-389
-
-
Fadul, C.E.1
Fisher, J.L.2
Hampton, T.H.3
Lallana, E.C.4
Li, Z.5
Gui, J.6
-
65
-
-
9144247794
-
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
-
Rutkowski S, De Vleeschouwer S, Kaempgen E, WolffJE, Kuhl J, Demaerel P, et al. Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. Br J Cancer (2004) 91(9):1656-62. doi:10.1038/sj.bjc.6602195
-
(2004)
Br J Cancer
, vol.91
, Issue.9
, pp. 1656-1662
-
-
Rutkowski, S.1
De Vleeschouwer, S.2
Kaempgen, E.3
Wolff, J.E.4
Kuhl, J.5
Demaerel, P.6
-
66
-
-
84901419097
-
Dendritic cell vaccination in glioblastoma after fluorescence-guided resection
-
Valle RD, de Cerio AL, Inoges S, Tejada S, Pastor F, Villanueva H, et al. Dendritic cell vaccination in glioblastoma after fluorescence-guided resection. World J Clin Oncol (2012) 3(11):142-9. doi:10.5306/wjco.v3.i11.142
-
(2012)
World J Clin Oncol
, vol.3
, Issue.11
, pp. 142-149
-
-
Valle, R.D.1
de Cerio, A.L.2
Inoges, S.3
Tejada, S.4
Pastor, F.5
Villanueva, H.6
-
67
-
-
84855597498
-
Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma
-
Jie X, Hua L, Jiang W, Feng F, Feng G, Hua Z. Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma. Cell Biochem Biophys (2012) 62(1):91-9. doi:10.1007/s12013-011-9265-6
-
(2012)
Cell Biochem Biophys
, vol.62
, Issue.1
, pp. 91-99
-
-
Jie, X.1
Hua, L.2
Jiang, W.3
Feng, F.4
Feng, G.5
Hua, Z.6
-
68
-
-
79954610784
-
Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells
-
Aguilera R, Saffie C, Tittarelli A, Gonzalez FE, Ramirez M, Reyes D, et al. Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells. Clin Cancer Res (2011) 17(8):2474-83. doi:10.1158/1078-0432.CCR-10-2384
-
(2011)
Clin Cancer Res
, vol.17
, Issue.8
, pp. 2474-2483
-
-
Aguilera, R.1
Saffie, C.2
Tittarelli, A.3
Gonzalez, F.E.4
Ramirez, M.5
Reyes, D.6
-
69
-
-
84864151615
-
Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
-
Cho DY, Yang WK, Lee HC, Hsu DM, Lin HL, Lin SZ, et al. Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial. World Neurosurg (2012) 77(5-6):736-44. doi:10.1016/j.wneu.2011.08.020
-
(2012)
World Neurosurg
, vol.77
, Issue.5-6
, pp. 736-744
-
-
Cho, D.Y.1
Yang, W.K.2
Lee, H.C.3
Hsu, D.M.4
Lin, H.L.5
Lin, S.Z.6
-
70
-
-
37549021127
-
Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
-
Walker DG, Laherty R, Tomlinson FH, Chuah T, Schmidt C. Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy. J Clin Neurosci (2008) 15(2):114-21. doi:10.1016/j.jocn.2007.08.007
-
(2008)
J Clin Neurosci
, vol.15
, Issue.2
, pp. 114-121
-
-
Walker, D.G.1
Laherty, R.2
Tomlinson, F.H.3
Chuah, T.4
Schmidt, C.5
-
71
-
-
84938324518
-
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
-
Adkins I, Fucikova J, Garg AD, Agostinis P, Spisek R. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology (2014) 3(12):e968434. doi:10.4161/21624011.2014.968434
-
(2014)
Oncoimmunology
, vol.3
, Issue.12
-
-
Adkins, I.1
Fucikova, J.2
Garg, A.D.3
Agostinis, P.4
Spisek, R.5
-
72
-
-
79961027880
-
Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
-
Zhang SN, Choi IK, Huang JH, Yoo JY, Choi KJ, Yun CO. Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF. Mol Ther (2011) 19(8):1558-68. doi:10.1038/mt.2011.29
-
(2011)
Mol Ther
, vol.19
, Issue.8
, pp. 1558-1568
-
-
Zhang, S.N.1
Choi, I.K.2
Huang, J.H.3
Yoo, J.Y.4
Choi, K.J.5
Yun, C.O.6
-
73
-
-
79959956606
-
Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
-
Woller N, Knocke S, Mundt B, Gurlevik E, Struver N, Kloos A, et al. Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice. J Clin Invest (2011) 121(7):2570-82. doi:10.1172/JCI45585
-
(2011)
J Clin Invest
, vol.121
, Issue.7
, pp. 2570-2582
-
-
Woller, N.1
Knocke, S.2
Mundt, B.3
Gurlevik, E.4
Struver, N.5
Kloos, A.6
-
74
-
-
84942095178
-
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
-
Schirrmacher V, Stucker W, Lulei M, Bihari AS, Sprenger T. Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report. Immunotherapy (2015) 7(8):855-60. doi:10.2217/imt.15.48
-
(2015)
Immunotherapy
, vol.7
, Issue.8
, pp. 855-860
-
-
Schirrmacher, V.1
Stucker, W.2
Lulei, M.3
Bihari, A.S.4
Sprenger, T.5
-
75
-
-
3042770952
-
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells
-
Jalili A, Makowski M, Switaj T, Nowis D, Wilczynski GM, Wilczek E, et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res (2004) 10(13):4498-508. doi:10.1158/1078-0432.CCR-04-0367
-
(2004)
Clin Cancer Res
, vol.10
, Issue.13
, pp. 4498-4508
-
-
Jalili, A.1
Makowski, M.2
Switaj, T.3
Nowis, D.4
Wilczynski, G.M.5
Wilczek, E.6
-
76
-
-
77953502765
-
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
-
Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med (2010) 207(6):1247-60. doi:10.1084/jem.20092140
-
(2010)
J Exp Med
, vol.207
, Issue.6
, pp. 1247-1260
-
-
Jongbloed, S.L.1
Kassianos, A.J.2
McDonald, K.J.3
Clark, G.J.4
Ju, X.5
Angel, C.E.6
-
77
-
-
77956046317
-
Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
-
Schreibelt G, Benitez-Ribas D, Schuurhuis D, Lambeck AJ, van Hout-Kuijer M, Schaft N, et al. Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells. Blood (2010) 116(4):564-74. doi:10.1182/blood-2009-11-251884
-
(2010)
Blood
, vol.116
, Issue.4
, pp. 564-574
-
-
Schreibelt, G.1
Benitez-Ribas, D.2
Schuurhuis, D.3
Lambeck, A.J.4
van Hout-Kuijer, M.5
Schaft, N.6
-
78
-
-
84900869746
-
Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets
-
Wimmers F, Schreibelt G, Skold AE, Figdor CG, De Vries IJ. Paradigm shift in dendritic cell-based immunotherapy: from in vitro generated monocyte-derived DCs to naturally circulating DC subsets. Front Immunol (2014) 5:165. doi:10.3389/fimmu.2014.00165
-
(2014)
Front Immunol
, vol.5
, pp. 165
-
-
Wimmers, F.1
Schreibelt, G.2
Skold, A.E.3
Figdor, C.G.4
De Vries, I.J.5
-
79
-
-
84873460701
-
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients
-
Tel J, Aarntzen EH, Baba T, Schreibelt G, Schulte BM, Benitez-Ribas D, et al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res (2013) 73(3):1063-75. doi:10.1158/0008-5472.CAN-12-2583
-
(2013)
Cancer Res
, vol.73
, Issue.3
, pp. 1063-1075
-
-
Tel, J.1
Aarntzen, E.H.2
Baba, T.3
Schreibelt, G.4
Schulte, B.M.5
Benitez-Ribas, D.6
-
80
-
-
84932170308
-
Dendritic cell-based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma
-
Dey M, Chang AL, Miska J, Wainwright DA, Ahmed AU, Balyasnikova IV, et al. Dendritic cell-based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma. J Immunol (2015) 195(1):367-76. doi:10.4049/jimmunol.1401607
-
(2015)
J Immunol
, vol.195
, Issue.1
, pp. 367-376
-
-
Dey, M.1
Chang, A.L.2
Miska, J.3
Wainwright, D.A.4
Ahmed, A.U.5
Balyasnikova, I.V.6
-
81
-
-
84884609956
-
Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy
-
Anguille S, Lion E, Van den Bergh J, Van Acker HH, Willemen Y, Smits EL, et al. Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy. Hum Vaccin Immunother (2013) 9(9):1956-61. doi:10.4161/hv.25373
-
(2013)
Hum Vaccin Immunother
, vol.9
, Issue.9
, pp. 1956-1961
-
-
Anguille, S.1
Lion, E.2
Van den Bergh, J.3
Van Acker, H.H.4
Willemen, Y.5
Smits, E.L.6
-
82
-
-
79953324723
-
Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo
-
Romano E, Rossi M, Ratzinger G, de Cos MA, Chung DJ, Panageas KS, et al. Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. Clin Cancer Res (2011) 17(7):1984-97. doi:10.1158/1078-0432.CCR-10-3421
-
(2011)
Clin Cancer Res
, vol.17
, Issue.7
, pp. 1984-1997
-
-
Romano, E.1
Rossi, M.2
Ratzinger, G.3
de Cos, M.A.4
Chung, D.J.5
Panageas, K.S.6
-
83
-
-
77349093500
-
Harnessing human dendritic cell subsets for medicine
-
Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G, et al. Harnessing human dendritic cell subsets for medicine. Immunol Rev (2010) 234(1):199-212. doi:10.1111/j.0105-2896.2009.00884.x
-
(2010)
Immunol Rev
, vol.234
, Issue.1
, pp. 199-212
-
-
Ueno, H.1
Schmitt, N.2
Klechevsky, E.3
Pedroza-Gonzalez, A.4
Matsui, T.5
Zurawski, G.6
-
84
-
-
84929121276
-
Interleukin-15 dendritic cells harness NK cell cytotoxic effector function in a contact-and IL-15-dependent manner
-
Anguille S, Van Acker HH, Van den Bergh J, Willemen Y, Goossens H, Van Tendeloo VF, et al. Interleukin-15 dendritic cells harness NK cell cytotoxic effector function in a contact-and IL-15-dependent manner. PLoS One (2015) 10(5):e0123340. doi:10.1371/journal.pone.0123340
-
(2015)
PLoS One
, vol.10
, Issue.5
-
-
Anguille, S.1
Van Acker, H.H.2
Van den Bergh, J.3
Willemen, Y.4
Goossens, H.5
Van Tendeloo, V.F.6
-
85
-
-
68249083949
-
Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity
-
Boudreau JE, Bridle BW, Stephenson KB, Jenkins KM, Brunelliere J, Bramson JL, et al. Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. Mol Ther (2009) 17(8):1465-72. doi:10.1038/mt.2009.95
-
(2009)
Mol Ther
, vol.17
, Issue.8
, pp. 1465-1472
-
-
Boudreau, J.E.1
Bridle, B.W.2
Stephenson, K.B.3
Jenkins, K.M.4
Brunelliere, J.5
Bramson, J.L.6
-
86
-
-
84868097958
-
NK cells: key to success of DC-based cancer vaccines?
-
Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. NK cells: key to success of DC-based cancer vaccines? Oncologist (2012) 17(10):1256-70. doi:10.1634/theoncologist.2011-0122
-
(2012)
Oncologist
, vol.17
, Issue.10
, pp. 1256-1270
-
-
Lion, E.1
Smits, E.L.2
Berneman, Z.N.3
Van Tendeloo, V.F.4
-
87
-
-
84911890607
-
Immunotherapy advances for glioblastoma
-
Reardon DA, Freeman G, Wu C, Chiocca EA, Wucherpfennig KW, Wen PY, et al. Immunotherapy advances for glioblastoma. Neuro Oncol (2014) 16(11):1441-58. doi:10.1093/neuonc/nou212
-
(2014)
Neuro Oncol
, vol.16
, Issue.11
, pp. 1441-1458
-
-
Reardon, D.A.1
Freeman, G.2
Wu, C.3
Chiocca, E.A.4
Wucherpfennig, K.W.5
Wen, P.Y.6
-
88
-
-
78049270536
-
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
-
Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, et al. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol (2010) 12(11):1113-25. doi:10.1093/neuonc/noq082
-
(2010)
Neuro Oncol
, vol.12
, Issue.11
, pp. 1113-1125
-
-
Wu, A.1
Wei, J.2
Kong, L.Y.3
Wang, Y.4
Priebe, W.5
Qiao, W.6
-
89
-
-
76049114698
-
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients
-
Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res (2010) 16(3):800-13. doi:10.1158/1078-0432.CCR-09-2730
-
(2010)
Clin Cancer Res
, vol.16
, Issue.3
, pp. 800-813
-
-
Di Tomaso, T.1
Mazzoleni, S.2
Wang, E.3
Sovena, G.4
Clavenna, D.5
Franzin, A.6
-
90
-
-
69249149701
-
Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
-
Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells (2009) 27(8):1734-40. doi:10.1002/stem.102
-
(2009)
Stem Cells
, vol.27
, Issue.8
, pp. 1734-1740
-
-
Xu, Q.1
Liu, G.2
Yuan, X.3
Xu, M.4
Wang, H.5
Ji, J.6
-
91
-
-
33751297619
-
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
-
Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, et al. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res (2006) 66(21):10247-52. doi:10.1158/0008-5472.CAN-06-2048
-
(2006)
Cancer Res
, vol.66
, Issue.21
, pp. 10247-10252
-
-
Pellegatta, S.1
Poliani, P.L.2
Corno, D.3
Menghi, F.4
Ghielmetti, F.5
Suarez-Merino, B.6
-
92
-
-
10744224631
-
Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients
-
de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, et al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. Clin Cancer Res (2003) 9(14):5091-100.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.14
, pp. 5091-5100
-
-
de Vries, I.J.1
Lesterhuis, W.J.2
Scharenborg, N.M.3
Engelen, L.P.4
Ruiter, D.J.5
Gerritsen, M.J.6
-
93
-
-
79955451697
-
Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
-
Draube A, Klein-Gonzalez N, Mattheus S, Brillant C, Hellmich M, Engert A, et al. Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis. PLoS One (2011) 6(4):e18801. doi:10.1371/journal.pone.0018801
-
(2011)
PLoS One
, vol.6
, Issue.4
-
-
Draube, A.1
Klein-Gonzalez, N.2
Mattheus, S.3
Brillant, C.4
Hellmich, M.5
Engert, A.6
-
94
-
-
20344372430
-
Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial
-
Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, et al. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res (2005) 11(11):4160-7. doi:10.1158/1078-0432.CCR-05-0120
-
(2005)
Clin Cancer Res
, vol.11
, Issue.11
, pp. 4160-4167
-
-
Yamanaka, R.1
Homma, J.2
Yajima, N.3
Tsuchiya, N.4
Sano, M.5
Kobayashi, T.6
-
95
-
-
80052439234
-
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
-
Lesterhuis WJ, de Vries IJ, Schreibelt G, Lambeck AJ, Aarntzen EH, Jacobs JF, et al. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res (2011) 17(17):5725-35. doi:10.1158/1078-0432.CCR-11-1261
-
(2011)
Clin Cancer Res
, vol.17
, Issue.17
, pp. 5725-5735
-
-
Lesterhuis, W.J.1
de Vries, I.J.2
Schreibelt, G.3
Lambeck, A.J.4
Aarntzen, E.H.5
Jacobs, J.F.6
-
96
-
-
69949142058
-
Dendritic cell therapy of high-grade gliomas
-
Van Gool S, Maes W, Ardon H, Verschuere T, Van Cauter S, De Vleeschouwer S. Dendritic cell therapy of high-grade gliomas. Brain Pathol (2009) 19(4):694-712. doi:10.1111/j.1750-3639.2009.00316.x
-
(2009)
Brain Pathol
, vol.19
, Issue.4
, pp. 694-712
-
-
Van Gool, S.1
Maes, W.2
Ardon, H.3
Verschuere, T.4
Van Cauter, S.5
De Vleeschouwer, S.6
-
97
-
-
2642631750
-
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions
-
Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 27(12):3135-42. doi:10.1002/eji.1830271209
-
(1997)
Eur J Immunol
, vol.27
, Issue.12
, pp. 3135-3142
-
-
Jonuleit, H.1
Kuhn, U.2
Muller, G.3
Steinbrink, K.4
Paragnik, L.5
Schmitt, E.6
-
98
-
-
0037137573
-
A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy
-
Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, Da Silva I, et al. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine (2002) 20(Suppl 4):A8-22. doi:10.1016/S0264-410X(02)00382-1
-
(2002)
Vaccine
, vol.20
, pp. A8-A22
-
-
Lee, A.W.1
Truong, T.2
Bickham, K.3
Fonteneau, J.F.4
Larsson, M.5
Da Silva, I.6
-
99
-
-
79951978155
-
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
-
Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, Donegan TE, et al. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol (2011) 29(3):330-6. doi:10.1200/JCO.2010.30.7744
-
(2011)
J Clin Oncol
, vol.29
, Issue.3
, pp. 330-336
-
-
Okada, H.1
Kalinski, P.2
Ueda, R.3
Hoji, A.4
Kohanbash, G.5
Donegan, T.E.6
-
100
-
-
84881222734
-
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity
-
Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, et al. IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest (2013) 123(8):3383-94. doi:10.1172/JCI68395
-
(2013)
J Clin Invest
, vol.123
, Issue.8
, pp. 3383-3394
-
-
Carreno, B.M.1
Becker-Hapak, M.2
Huang, A.3
Chan, M.4
Alyasiry, A.5
Lie, W.R.6
-
101
-
-
46949095104
-
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
-
Lee JJ, Foon KA, Mailliard RB, Muthuswamy R, Kalinski P. Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia. J Leukoc Biol (2008) 84(1):319-25. doi:10.1189/jlb.1107737
-
(2008)
J Leukoc Biol
, vol.84
, Issue.1
, pp. 319-325
-
-
Lee, J.J.1
Foon, K.A.2
Mailliard, R.B.3
Muthuswamy, R.4
Kalinski, P.5
-
102
-
-
4344596051
-
alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity
-
Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, et al. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res (2004) 64(17):5934-7. doi:10.1158/0008-5472.CAN-04-1261
-
(2004)
Cancer Res
, vol.64
, Issue.17
, pp. 5934-5937
-
-
Mailliard, R.B.1
Wankowicz-Kalinska, A.2
Cai, Q.3
Wesa, A.4
Hilkens, C.M.5
Kapsenberg, M.L.6
-
103
-
-
33748693100
-
Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity
-
Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, et al. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother (2006) 29(5):545-57. doi:10.1097/01.cji.0000211309.90621.8b
-
(2006)
J Immunother
, vol.29
, Issue.5
, pp. 545-557
-
-
Palucka, A.K.1
Ueno, H.2
Connolly, J.3
Kerneis-Norvell, F.4
Blanck, J.P.5
Johnston, D.A.6
-
104
-
-
55749115774
-
Antigens for cancer immunotherapy
-
Neller MA, Lopez JA, Schmidt CW. Antigens for cancer immunotherapy. Semin Immunol (2008) 20(5):286-95. doi:10.1016/j.smim.2008.09.006
-
(2008)
Semin Immunol
, vol.20
, Issue.5
, pp. 286-295
-
-
Neller, M.A.1
Lopez, J.A.2
Schmidt, C.W.3
-
105
-
-
84873989551
-
Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
-
Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, et al. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother (2013) 36(2):152-7. doi:10.1097/CJI.0b013e3182811ae4
-
(2013)
J Immunother
, vol.36
, Issue.2
, pp. 152-157
-
-
Prins, R.M.1
Wang, X.2
Soto, H.3
Young, E.4
Lisiero, D.N.5
Fong, B.6
-
106
-
-
0026046214
-
Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity
-
Begovic M, Herberman RB, Gorelik E. Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity. Cell Immunol (1991) 138(2):349-59. doi:10.1016/0008-8749(91)90159-9
-
(1991)
Cell Immunol
, vol.138
, Issue.2
, pp. 349-359
-
-
Begovic, M.1
Herberman, R.B.2
Gorelik, E.3
-
107
-
-
0027484774
-
Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis
-
Begovic M, Herberman RB, Gorelik E. Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis. Nat Immun (1993) 12(4-5):250-66.
-
(1993)
Nat Immun
, vol.12
, Issue.4-5
, pp. 250-266
-
-
Begovic, M.1
Herberman, R.B.2
Gorelik, E.3
-
108
-
-
84883477049
-
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage
-
Mar VJ, Wong SQ, Li J, Scolyer RA, McLean C, Papenfuss AT, et al. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. Clin Cancer Res (2013) 19(17):4589-98. doi:10.1158/1078-0432.CCR-13-0398
-
(2013)
Clin Cancer Res
, vol.19
, Issue.17
, pp. 4589-4598
-
-
Mar, V.J.1
Wong, S.Q.2
Li, J.3
Scolyer, R.A.4
McLean, C.5
Papenfuss, A.T.6
-
109
-
-
33646396792
-
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
-
Guevara-Patino JA, Engelhorn ME, Turk MJ, Liu C, Duan F, Rizzuto G, et al. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J Clin Invest (2006) 116(5):1382-90. doi:10.1172/JCI25591
-
(2006)
J Clin Invest
, vol.116
, Issue.5
, pp. 1382-1390
-
-
Guevara-Patino, J.A.1
Engelhorn, M.E.2
Turk, M.J.3
Liu, C.4
Duan, F.5
Rizzuto, G.6
-
110
-
-
0025077359
-
Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load
-
Harmon BV, Corder AM, Collins RJ, Gobe GC, Allen J, Allan DJ, et al. Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiat Biol (1990) 58(5):845-58. doi:10.1080/09553009014552221
-
(1990)
Int J Radiat Biol
, vol.58
, Issue.5
, pp. 845-858
-
-
Harmon, B.V.1
Corder, A.M.2
Collins, R.J.3
Gobe, G.C.4
Allen, J.5
Allan, D.J.6
-
111
-
-
84870239310
-
Immunogenic cell death and DAMPs in cancer therapy
-
Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer (2012) 12(12):860-75. doi:10.1038/nrc3380
-
(2012)
Nat Rev Cancer
, vol.12
, Issue.12
, pp. 860-875
-
-
Krysko, D.V.1
Garg, A.D.2
Kaczmarek, A.3
Krysko, O.4
Agostinis, P.5
Vandenabeele, P.6
-
112
-
-
84883785740
-
Inducers of immunogenic cancer cell death
-
Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P. Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev (2013) 24(4):319-33. doi:10.1016/j.cytogfr.2013.01.005
-
(2013)
Cytokine Growth Factor Rev
, vol.24
, Issue.4
, pp. 319-333
-
-
Dudek, A.M.1
Garg, A.D.2
Krysko, D.V.3
De Ruysscher, D.4
Agostinis, P.5
-
113
-
-
84949681065
-
Molecular and translational classifications of DAMPs in immunogenic cell death
-
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, et al. Molecular and translational classifications of DAMPs in immunogenic cell death. Front Immunol (2015) 6:588. doi:10.3389/fimmu.2015.00588
-
(2015)
Front Immunol
, vol.6
, pp. 588
-
-
Garg, A.D.1
Galluzzi, L.2
Apetoh, L.3
Baert, T.4
Birge, R.B.5
Bravo-San Pedro, J.M.6
-
114
-
-
84863658629
-
Basic principles of molecular effects of irradiation
-
Selzer E, Hebar A. Basic principles of molecular effects of irradiation. Wien Med Wochenschr (2012) 162(3-4):47-54. doi:10.1007/s10354-012-0052-9
-
(2012)
Wien Med Wochenschr
, vol.162
, Issue.3-4
, pp. 47-54
-
-
Selzer, E.1
Hebar, A.2
-
115
-
-
1242315588
-
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
-
Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys (2004) 58(3):862-70. doi:10.1016/j.ijrobp.2003.09.012
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, Issue.3
, pp. 862-870
-
-
Demaria, S.1
Ng, B.2
Devitt, M.L.3
Babb, J.S.4
Kawashima, N.5
Liebes, L.6
-
116
-
-
84861108403
-
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors
-
Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors. Semin Oncol (2012) 39(3):323-39. doi:10.1053/j.seminoncol.2012.02.006
-
(2012)
Semin Oncol
, vol.39
, Issue.3
, pp. 323-339
-
-
Hodge, J.W.1
Ardiani, A.2
Farsaci, B.3
Kwilas, A.R.4
Gameiro, S.R.5
-
117
-
-
59449108329
-
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
-
Di Nicola M, Zappasodi R, Carlo-Stella C, Mortarini R, Pupa SM, Magni M, et al. Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study. Blood (2009) 113(1):18-27. doi:10.1182/blood-2008-06-165654
-
(2009)
Blood
, vol.113
, Issue.1
, pp. 18-27
-
-
Di Nicola, M.1
Zappasodi, R.2
Carlo-Stella, C.3
Mortarini, R.4
Pupa, S.M.5
Magni, M.6
-
118
-
-
0026235940
-
Clinical trial on the effects of shikonin mixture on later stage lung cancer
-
Guo XP, Zhang XY, Zhang SD. [Clinical trial on the effects of shikonin mixture on later stage lung cancer]. Zhong Xi Yi Jie He Za Zhi (1991) 11(10):598-9.
-
(1991)
Zhong Xi Yi Jie He Za Zhi
, vol.11
, Issue.10
, pp. 598-599
-
-
Guo, X.P.1
Zhang, X.Y.2
Zhang, S.D.3
-
119
-
-
1242306739
-
Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin
-
Chen CH, Chern CL, Lin CC, Lu FJ, Shih MK, Hsieh PY, et al. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med (2003) 69(12):1119-24. doi:10.1055/s-2003-45193
-
(2003)
Planta Med
, vol.69
, Issue.12
, pp. 1119-1124
-
-
Chen, C.H.1
Chern, C.L.2
Lin, C.C.3
Lu, F.J.4
Shih, M.K.5
Hsieh, P.Y.6
-
120
-
-
64249097600
-
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo
-
Yang H, Zhou P, Huang H, Chen D, Ma N, Cui QC, et al. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Int J Cancer (2009) 124(10):2450-9. doi:10.1002/ijc.24195
-
(2009)
Int J Cancer
, vol.124
, Issue.10
, pp. 2450-2459
-
-
Yang, H.1
Zhou, P.2
Huang, H.3
Chen, D.4
Ma, N.5
Cui, Q.C.6
-
121
-
-
21644476266
-
Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis
-
Frey B, Franz S, SheriffA, Korn A, Bluemelhuber G, Gaipl US, et al. Hydrostatic pressure induced death of mammalian cells engages pathways related to apoptosis or necrosis. Cell Mol Biol (2004) 50(4):459-67.
-
(2004)
Cell Mol Biol
, vol.50
, Issue.4
, pp. 459-467
-
-
Frey, B.1
Franz, S.2
Sheriff, A.3
Korn, A.4
Bluemelhuber, G.5
Gaipl, U.S.6
-
122
-
-
55249091823
-
Cells under pressure-treatment of eukaryotic cells with high hydrostatic pressure, from physiologic aspects to pressure induced cell death
-
Frey B, Janko C, Ebel N, Meister S, Schlucker E, Meyer-PittroffR, et al. Cells under pressure-treatment of eukaryotic cells with high hydrostatic pressure, from physiologic aspects to pressure induced cell death. Curr Med Chem (2008) 15(23):2329-36. doi:10.2174/092986708785909166
-
(2008)
Curr Med Chem
, vol.15
, Issue.23
, pp. 2329-2336
-
-
Frey, B.1
Janko, C.2
Ebel, N.3
Meister, S.4
Schlucker, E.5
Meyer-Pittroff, R.6
-
123
-
-
21644467346
-
High hydrostatic pressure inactivated human tumour cells preserve their immunogenicity
-
Korn A, Frey B, SheriffA, Gaipl US, Franz S, Meyer-PittroffR, et al. High hydrostatic pressure inactivated human tumour cells preserve their immunogenicity. Cell Mol Biol (2004) 50(4):469-77.
-
(2004)
Cell Mol Biol
, vol.50
, Issue.4
, pp. 469-477
-
-
Korn, A.1
Frey, B.2
Sheriff, A.3
Gaipl, U.S.4
Franz, S.5
Meyer-Pittroff, R.6
-
124
-
-
0015380846
-
Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases
-
Helmstein K. Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases. Br J Urol (1972) 44(4):434-50. doi:10.1111/j.1464-410X.1972.tb10103.x
-
(1972)
Br J Urol
, vol.44
, Issue.4
, pp. 434-450
-
-
Helmstein, K.1
-
125
-
-
0027528550
-
Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking
-
Eisenthal A, Ramakrishna V, Skornick Y, Shinitzky M. Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking. Cancer Immunol Immunother (1993) 36(5):300-6. doi:10.1007/BF01741168
-
(1993)
Cancer Immunol Immunother
, vol.36
, Issue.5
, pp. 300-306
-
-
Eisenthal, A.1
Ramakrishna, V.2
Skornick, Y.3
Shinitzky, M.4
-
126
-
-
0034650884
-
Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine
-
Goldman Y, Peled A, Shinitzky M. Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine. Cancer Res (2000) 60(2):350-8.
-
(2000)
Cancer Res
, vol.60
, Issue.2
, pp. 350-358
-
-
Goldman, Y.1
Peled, A.2
Shinitzky, M.3
-
127
-
-
77954934585
-
High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features
-
Weiss EM, Meister S, Janko C, Ebel N, Schlucker E, Meyer-PittroffR, et al. High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features. J Immunotoxicol (2010) 7(3):194-204. doi:10.3109/15476911003657414
-
(2010)
J Immunotoxicol
, vol.7
, Issue.3
, pp. 194-204
-
-
Weiss, E.M.1
Meister, S.2
Janko, C.3
Ebel, N.4
Schlucker, E.5
Meyer-Pittroff, R.6
-
128
-
-
84923695620
-
Immune suppression during oncolytic virotherapy for high-grade glioma. Yes or No?
-
Koks CA, De Vleeschouwer S, Graf N, Van Gool SW. Immune suppression during oncolytic virotherapy for high-grade glioma. Yes or No? J Cancer (2015) 6(3):203-17. doi:10.7150/jca.10640
-
(2015)
J Cancer
, vol.6
, Issue.3
, pp. 203-217
-
-
Koks, C.A.1
De Vleeschouwer, S.2
Graf, N.3
Van Gool, S.W.4
-
129
-
-
80051580475
-
Photodynamic therapy of cancer: an update
-
Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 61(4):250-81. doi:10.3322/caac.20114
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.4
, pp. 250-281
-
-
Agostinis, P.1
Berg, K.2
Cengel, K.A.3
Foster, T.H.4
Girotti, A.W.5
Gollnick, S.O.6
-
130
-
-
84859240988
-
In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells
-
Garg AD, Bose M, Ahmed MI, Bonass WA, Wood SR. In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells. PLoS One (2012) 7(4):e34475. doi:10.1371/journal.pone.0034475
-
(2012)
PLoS One
, vol.7
, Issue.4
-
-
Garg, A.D.1
Bose, M.2
Ahmed, M.I.3
Bonass, W.A.4
Wood, S.R.5
-
131
-
-
77956927110
-
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
-
Garg AD, Nowis D, Golab J, Agostinis P. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis (2010) 15(9):1050-71. doi:10.1007/s10495-010-0479-7
-
(2010)
Apoptosis
, vol.15
, Issue.9
, pp. 1050-1071
-
-
Garg, A.D.1
Nowis, D.2
Golab, J.3
Agostinis, P.4
-
132
-
-
84894445642
-
ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
-
Garg AD, Agostinis P. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem Photobiol Sci (2014) 13(3):474-87. doi:10.1039/c3pp50333j
-
(2014)
Photochem Photobiol Sci
, vol.13
, Issue.3
, pp. 474-487
-
-
Garg, A.D.1
Agostinis, P.2
-
133
-
-
84860401844
-
Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro
-
Etminan N, Peters C, Lakbir D, Bunemann E, Borger V, Sabel MC, et al. Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br J Cancer (2011) 105(7):961-9. doi:10.1038/bjc.2011.327
-
(2011)
Br J Cancer
, vol.105
, Issue.7
, pp. 961-969
-
-
Etminan, N.1
Peters, C.2
Lakbir, D.3
Bunemann, E.4
Borger, V.5
Sabel, M.C.6
-
134
-
-
80052050425
-
Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70
-
Mitra S, Giesselman BR, De Jesus-Andino FJ, Foster TH. Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70. Lasers Surg Med (2011) 43(7):632-43. doi:10.1002/lsm.21108
-
(2011)
Lasers Surg Med
, vol.43
, Issue.7
, pp. 632-643
-
-
Mitra, S.1
Giesselman, B.R.2
De Jesus-Andino, F.J.3
Foster, T.H.4
-
135
-
-
84936856118
-
Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells
-
Panzarini E, Inguscio V, Fimia GM, Dini L. Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells. PLoS One (2014) 9(8):e105778. doi:10.1371/journal.pone.0105778
-
(2014)
PLoS One
, vol.9
, Issue.8
-
-
Panzarini, E.1
Inguscio, V.2
Fimia, G.M.3
Dini, L.4
-
136
-
-
84870984470
-
PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress
-
Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ (2012) 19(11):1880-91. doi:10.1038/cdd.2012.74
-
(2012)
Cell Death Differ
, vol.19
, Issue.11
, pp. 1880-1891
-
-
Verfaillie, T.1
Rubio, N.2
Garg, A.D.3
Bultynck, G.4
Rizzuto, R.5
Decuypere, J.P.6
-
137
-
-
84855927363
-
Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma
-
Sanovic R, Verwanger T, Hartl A, Krammer B. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. Photodiagnosis Photodyn Ther (2011) 8(4):291-6. doi:10.1016/j.pdpdt.2011.04.003
-
(2011)
Photodiagnosis Photodyn Ther
, vol.8
, Issue.4
, pp. 291-296
-
-
Sanovic, R.1
Verwanger, T.2
Hartl, A.3
Krammer, B.4
-
138
-
-
84864036920
-
Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors
-
Jung NC, Kim HJ, Kang MS, Lee JH, Song JY, Seo HG, et al. Photodynamic therapy-mediated DC immunotherapy is highly effective for the inhibition of established solid tumors. Cancer Lett (2012) 324(1):58-65. doi:10.1016/j.canlet.2012.04.024
-
(2012)
Cancer Lett
, vol.324
, Issue.1
, pp. 58-65
-
-
Jung, N.C.1
Kim, H.J.2
Kang, M.S.3
Lee, J.H.4
Song, J.Y.5
Seo, H.G.6
-
139
-
-
48649096955
-
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
-
Wheeler CJ, Black KL, Liu G, Mazer M, Zhang XX, Pepkowitz S, et al. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Cancer Res (2008) 68(14):5955-64. doi:10.1158/0008-5472.CAN-07-5973
-
(2008)
Cancer Res
, vol.68
, Issue.14
, pp. 5955-5964
-
-
Wheeler, C.J.1
Black, K.L.2
Liu, G.3
Mazer, M.4
Zhang, X.X.5
Pepkowitz, S.6
-
140
-
-
70349680756
-
Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
-
Ribas A, Comin-Anduix B, Chmielowski B, Jalil J, de la Rocha P, McCannel TA, et al. Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res (2009) 15(19):6267-76. doi:10.1158/1078-0432.CCR-09-1254
-
(2009)
Clin Cancer Res
, vol.15
, Issue.19
, pp. 6267-6276
-
-
Ribas, A.1
Comin-Anduix, B.2
Chmielowski, B.3
Jalil, J.4
de la Rocha, P.5
McCannel, T.A.6
-
141
-
-
84935119447
-
Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy
-
Datta J, Berk E, Cintolo JA, Xu S, Roses RE, Czerniecki BJ. Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy. Front Immunol (2015) 6:271. doi:10.3389/fimmu.2015.00271
-
(2015)
Front Immunol
, vol.6
, pp. 271
-
-
Datta, J.1
Berk, E.2
Cintolo, J.A.3
Xu, S.4
Roses, R.E.5
Czerniecki, B.J.6
|